Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Serum Metabolite Based PrecogColo Dx Test for Advanced Colorectal Neoplasia Screening

NCT05870696 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05870696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Serum Metabolite Based PrecogColo Dx Test for Advanced Colorectal Neoplasia Screening
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2023
Completion date
February 27, 2024
Enrollment
2,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma